Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Pharmacoeconomics|February 25, 2018
Comparing the UK EQ-5D-3L and English EQ-5D-5L Value SetsBrendan Mulhern, Yan Feng, Koonal Shah, et al.
Pharmacoeconomics|April 17, 2020
International Valuation Protocol for the EQ-5D-Y-3LJuan M Ramos-Goñi, Mark Oppe, Elly Stolk, et al.
Scientific Reports|December 14, 2021
Cardiovascular outcomes of type 2 diabetic patients treated with DPP‑4 inhibitors versus sulphonylureas as add-on to metformin in clinical practiceJuan Carlos Bazo-Alvarez, Kingshuk Pal, Tra My Pham, et al.
Health Policy (Amsterdam, Netherlands)|May 7, 2020
Do people with private health insurance attach a higher value to health than those without insurance? Results from an EQ-5D-5 L valuation study in IrelandAnna P Hobbins, Luke Barry, Dan Kelleher, et al.
Clinical Epidemiology|July 2, 2020
Impact of Being Eligible for Type 2 Diabetes Treatment on All-Cause Mortality and Cardiovascular Events: Regression Discontinuity Design StudyIrene Petersen, Sia Kromann Nicolaisen, Federico Ricciardi, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 5, 2022
Does Changing the Age of a Child to be Considered in 3-Level Version of EQ-5D-Y Discrete Choice Experiment-Based Valuation Studies Affect Health Preferences?Juan M Ramos-Goñi, Anabel Estévez-Carrillo, Oliver Rivero-Arias, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 19, 2018
Evaluation of Split Version and Feedback Module on the Improvement of Time Trade-Off DataEliza L Y Wong, Koonal Shah, Annie W L Cheung, et al.
Pharmacoeconomics|February 7, 2026
Are Health Gains to Children and Adolescents More Important Than Health Gains to Adults? A Person Trade-Off StudyTessa Peasgood, Udeni De Silva Perera, Gang Chen, et al.
The Patient|February 29, 2024
Using Patient Preferences in Health Technology Assessment: Evaluating Quality-Adjusted Survival Equivalents (QASE) for the Quantification of Non-health BenefitsKevin Marsh, Hannah Collacott, Jim Thomson, et al.
Social Science & Medicine (1982)|August 15, 2022
Assessing the comparative feasibility, acceptability and equivalence of videoconference interviews and face-to-face interviews using the time trade-off techniqueDonna Rowen, Clara Mukuria, Nathan Bray, et al.
Pageof 7